Developing Preventative Vaccines for Infectious Diseases with Thomas Lingelbach Valneva

Published: Oct. 1, 2019, 5:18 p.m.

Thomas Lingelbach, CEO, Valneva talks about their work developing and commercializing vaccines for infectious diseases with unmet needs.\xa0 This biotech company is in development of a Lyme disease vaccine and vaccines for mosquito-borne illnesses such as Zika and chikungunya. Thomas talks about the challenges of testing vaccines to prevent a disease within a healthy population and why it is impossible to eliminate all the vectors that can transmit a disease.

@ValnevaSE

#Lyme #LymeDisease\xa0 #chikungunya

Valneva.com

Download the transcript here

Additional links:

Chikungunya Fact Sheet

Lyme Fact Sheet

World Health Organization Zika virus resources

World Health Organization Japanese encephalitis resources

\xa0

\xa0